| 1. Executive Summary |
| 2. Global Smoking Cessation Aids Market Introduction |
| 2.1. Global Smoking Cessation Aids Market – Taxonomy |
| 2.2. Global Smoking Cessation Aids Market –Definitions |
| 2.2.1. Product Type |
| 2.2.2. Distribution Channel |
| 3. Global Smoking Cessation Aids Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Smoking Cessation Aids Market Dynamic Factors - Impact Analysis |
| 3.6. Global Smoking Cessation Aids Market – Competition Landscape |
| 4. Global Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Smoking Cessation Aids Market, By Product Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1. Nicotine Replacement Therapy |
| 5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Drugs |
| 5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Electronic Cigarettes |
| 5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Smoking Cessation Aids Market Forecast, By Distribution Channel, 2017 - 2021 and Forecast, 2022 - 2028 |
| 6.1. Hospital Pharmacies |
| 6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Online Channel |
| 6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Retail Pharmacies |
| 6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Smoking Cessation Aids Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Region, 2022 - 2028 |
| 8. North America Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1. By Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Nicotine Replacement Therapy |
| 8.1.2. Drugs |
| 8.1.3. Electronic Cigarettes |
| 8.1.4. Others |
| 8.2. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Hospital Pharmacies |
| 8.2.2. Online Channel |
| 8.2.3. Retail Pharmacies |
| 8.2.4. Others |
| 8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 - 2028 |
| 8.5. North America Smoking Cessation Aids Market Dynamics – Trends |
| 9. Europe Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1. By Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Nicotine Replacement Therapy |
| 9.1.2. Drugs |
| 9.1.3. Electronic Cigarettes |
| 9.1.4. Others |
| 9.2. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Hospital Pharmacies |
| 9.2.2. Online Channel |
| 9.2.3. Retail Pharmacies |
| 9.2.4. Others |
| 9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 - 2028 |
| 9.5. Europe Smoking Cessation Aids Market Dynamics – Trends |
| 10. Asia-Pacific Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1. By Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Nicotine Replacement Therapy |
| 10.1.2. Drugs |
| 10.1.3. Electronic Cigarettes |
| 10.1.4. Others |
| 10.2. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Hospital Pharmacies |
| 10.2.2. Online Channel |
| 10.2.3. Retail Pharmacies |
| 10.2.4. Others |
| 10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 - 2028 |
| 10.5. Asia-Pacific Smoking Cessation Aids Market Dynamics – Trends |
| 11. Latin America Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 11.1. By Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Nicotine Replacement Therapy |
| 11.1.2. Drugs |
| 11.1.3. Electronic Cigarettes |
| 11.1.4. Others |
| 11.2. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Hospital Pharmacies |
| 11.2.2. Online Channel |
| 11.2.3. Retail Pharmacies |
| 11.2.4. Others |
| 11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 - 2028 |
| 11.5. Latin America Smoking Cessation Aids Market Dynamics – Trends |
| 12. Middle East and Africa Smoking Cessation Aids Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 12.1. By Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Nicotine Replacement Therapy |
| 12.1.2. Drugs |
| 12.1.3. Electronic Cigarettes |
| 12.1.4. Others |
| 12.2. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Hospital Pharmacies |
| 12.2.2. Online Channel |
| 12.2.3. Retail Pharmacies |
| 12.2.4. Others |
| 12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Smoking Cessation Aids Market - Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 - 2028 |
| 12.5. MEA Smoking Cessation Aids Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Distribution Channel & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Johnson and Johnson |
| 13.2.2. GlaxoSmithKline Plc |
| 13.2.3. Pfizer Inc. |
| 13.2.4. Cipla Inc. |
| 13.2.5. Dr. Reddy's Laboratories |
| 13.2.6. Novartis AG |
| 13.2.7. NJOY |
| 13.2.8. Takeda Pharmaceuticals Co. Ltd. |
| 13.2.9. Glenmark Pharmaceuticals Ltd. |
| 13.2.10. Philip Morris International Inc. |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
hghLatin America Got Significant Share
Smoking Cessation Aids Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share and forecast from 2021-2027
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Johnson and Johnson
- GlaxoSmithKline Plc
- Pfizer Inc.
- Cipla Inc.
- Dr. Reddy's Laboratories
- Novartis AG
- NJOY
- Takeda Pharmaceuticals Co. Ltd.
- Glenmark Pharmaceuticals Ltd.
- Philip Morris International Inc.